Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-535.97M
↓ 34% below average
Average (9y)
$-398.62M
Historical baseline
Range
High:$-147.74M
Low:$-648.92M
CAGR
+15.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-535.97M | +5.8% |
| 2023 | $-569.21M | +12.3% |
| 2022 | $-648.92M | -70.0% |
| 2021 | $-381.74M | -15.6% |
| 2020 | $-330.12M | +22.2% |
| 2019 | $-424.17M | -14.2% |
| 2018 | $-371.37M | -12.9% |
| 2017 | $-328.94M | -32.6% |
| 2016 | $-248.01M | -67.9% |
| 2015 | $-147.74M | - |